TherapeutAix (www.therapeutaix.com) is a drug discovery consultancy company based in Aachen, Germany, combining research and development expertise with a fully integrated R&D network, to deliver practical, cost- and time-effective solutions to drug discovery projects. It supports investors and project teams focus on the next step, and progress the right assets through robust decision-making steps, with a clear line of sight to the next value-inflection point and the clinic. Since its formation in 2018, TherapeutAix has successfully conducted project reviews, developed strategies and operationalised programmes for biotech, pharma and investors in diverse therapeutic areas including fibrosis, inflammation, and respiratory disease.